Jun Liu
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Jun Liu has a total of 85 co-authors. Here are the top co-authors by number of shared publications:
- Chaoqun Han
Division of Gastroenterology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei, China
7 shared publications - Rong Lin
Department of Gastroenterology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China
6 shared publications - Yu Jin
Division of Gastroenterology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China
5 shared publications - Zhen Ding
Endoscopy Center, The First Affiliated Hospital of Sun Yat-sen University, Guangzhou, Guangdong Province, China
5 shared publications Bo Liu
4 shared publicationsJingui Qin
Department of Chemistry, Hubei Key Laboratory on Organic and Polymeric Opto-Electronic Materials, Wuhan University, 430072, P. R. China
4 shared publications
Latest Publications
- Open Access
- 26 October 2026
- Published by Wolters Kluwer Health in Journal of Clinical Gastroenterology
Distributed Sample Allocation for the Diagnosis of Mass Lesions by EUS-FNA
Background: Endoscopic ultrasound-guided fine needle aspiration (EUS-FNA)is a well-established, minimally invasive, interventional diagnostic endoscopic technique for the identification of mass lesions; however, its diagnostic accuracy needs further improvement. Most previous studies have focused on the choice of puncture techniques, and rare studies have investigated the effect of distributed sample allocation on the diagnostic accuracy of EUS-FNA. In this study, we aim to investigate the effect of distributed versus nondistributed sample allocation on EUS-FNA diagnostic accuracy. Methods: A total of 248 patients with mass lesions indicated by previous imaging examination were enrolled in this study. The patients were randomly assigned to 2 groups: distributed and nondistributed sample allocation. Clinicopathological features were collected retrospectively and analyzed. Results: Distributed sample allocation can raise the overall EUS-FNA diagnostic accuracy from 88.31% (nondistributed preservation) to 96.34% (distributed preservation). Distributed sample allocation was effective to further increase EUS-FNA diagnostic accuracy ( P =0.0262). Furthermore, for lesions of different locations, the diagnostic accuracy of EUS-FNA of lesions in the mediastinum and lung has improved ( P =0.0128). For lesions of different echogenicity, distributed allocation has effectively improved the diagnostic rate in cystic solid lesions ( P =0.0235). Conclusion: As a rarely considered approach, distributed sample allocation can improve the overall diagnostic accuracy of EUS-FNA.
- 26 October 2026
- Published by Wolters Kluwer Health in Journal of Clinical Gastroenterology
Open AccessDistributed Sample Allocation for the Diagnosis of Mass Lesions by EUS-FNA
Background: Endoscopic ultrasound-guided fine needle aspiration (EUS-FNA)is a well-established, minimally invasive, interventional diagnostic endoscopic technique for the identification of mass lesions; however, its diagnostic accuracy needs further improvement. Most previous studies have focused on the choice of puncture techniques, and rare studies have investigated the effect of distributed sample allocation on the diagnostic accuracy of EUS-FNA. In this study, we aim to investigate the effect of distributed versus nondistributed sample allocation on EUS-FNA diagnostic accuracy. Methods: A total of 248 patients with mass lesions indicated by previous imaging examination were enrolled in this study. The patients were randomly assigned to 2 groups: distributed and nondistributed sample allocation. Clinicopathological features were collected retrospectively and analyzed. Results: Distributed sample allocation can raise the overall EUS-FNA diagnostic accuracy from 88.31% (nondistributed preservation) to 96.34% (distributed preservation). Distributed sample allocation was effective to further increase EUS-FNA diagnostic accuracy ( P =0.0262). Furthermore, for lesions of different locations, the diagnostic accuracy of EUS-FNA of lesions in the mediastinum and lung has improved ( P =0.0128). For lesions of different echogenicity, distributed allocation has effectively improved the diagnostic rate in cystic solid lesions ( P =0.0235). Conclusion: As a rarely considered approach, distributed sample allocation can improve the overall diagnostic accuracy of EUS-FNA.
- Open Access
- 15 April 2026
- Published by Springer Nature in BMC Surgery
- Vol. 26 (1)
Evaluation of short-term outcomes of Endoscopic Super-Hemorrhoidal Banding for mixed hemorrhoids with prolapsed internal hemorrhoids: a retrospective study
To evaluate the clinical efficacy and safety of Endoscopic Super-hemorrhoidal Banding (ESHB) in treating mixed hemorrhoids with Grade II-IV internal hemorr
- 15 April 2026
- Published by Springer Nature in BMC Surgery
- Vol. 26 (1)
Open AccessEvaluation of short-term outcomes of Endoscopic Super-Hemorrhoidal Banding for mixed hemorrhoids with prolapsed internal hemorrhoids: a retrospective study
To evaluate the clinical efficacy and safety of Endoscopic Super-hemorrhoidal Banding (ESHB) in treating mixed hemorrhoids with Grade II-IV internal hemorr
- Open Access
- 26 September 2025
- Published by MDPI AG in Diagnostics
- Vol. 15 (19) , 2470
Diagnostic Value of EUS-FNA in the Differential Diagnosis of Esophageal Strictures Lacking Typical Malignant Features
Background: Esophageal strictures lacking typical malignant endoscopic features present a significant diagnostic challenge, often mimicking malignancy on imaging while concealing their true nature under regular white-light endoscopy. This study evaluated the utility of EUS-FNA in the differential diagnosis of such indeterminate strictures. Methods: We retrospectively analyzed 38 patients with suspicious malignant esophageal strictures indicated by CT but lacking definite malignant features on initial white-light gastroscopy. All patients underwent EUS-FNA for definitive pathological diagnosis. Clinicopathological data, imaging reports, endoscopic mucosal features, and procedural outcomes were assessed. Results: Among all 38 patients suspected of esophageal cancer by CT scan, 30 of them had malignant cytology results, including ESCC, EAC, metastatic cancer, and esophageal lymphoma. A total of 8 patients had benign findings, including esophageal tuberculosis, fungal esophagitis, eosinophilic esophagitis, and esophageal varices. Critically, EUS-FNA identified benign entities, such as eosinophilic esophagitis and esophageal tuberculosis masquerading as malignancy. CT features and mucosal features are also summarized and analyzed. Conclusions: EUS-FNA is a powerful tool for diagnosing esophageal strictures lacking typical malignant features. It reliably differentiates malignancy from challenging benign mimics, preventing misdiagnosis and guiding appropriate therapy. Clinicians should maintain a high suspicion for both occult malignancy and rare benign conditions in such stenotic lesions.
- 26 September 2025
- Published by MDPI AG in Diagnostics
- Vol. 15 (19) , 2470
Open AccessDiagnostic Value of EUS-FNA in the Differential Diagnosis of Esophageal Strictures Lacking Typical Malignant Features
Background: Esophageal strictures lacking typical malignant endoscopic features present a significant diagnostic challenge, often mimicking malignancy on imaging while concealing their true nature under regular white-light endoscopy. This study evaluated the utility of EUS-FNA in the differential diagnosis of such indeterminate strictures. Methods: We retrospectively analyzed 38 patients with suspicious malignant esophageal strictures indicated by CT but lacking definite malignant features on initial white-light gastroscopy. All patients underwent EUS-FNA for definitive pathological diagnosis. Clinicopathological data, imaging reports, endoscopic mucosal features, and procedural outcomes were assessed. Results: Among all 38 patients suspected of esophageal cancer by CT scan, 30 of them had malignant cytology results, including ESCC, EAC, metastatic cancer, and esophageal lymphoma. A total of 8 patients had benign findings, including esophageal tuberculosis, fungal esophagitis, eosinophilic esophagitis, and esophageal varices. Critically, EUS-FNA identified benign entities, such as eosinophilic esophagitis and esophageal tuberculosis masquerading as malignancy. CT features and mucosal features are also summarized and analyzed. Conclusions: EUS-FNA is a powerful tool for diagnosing esophageal strictures lacking typical malignant features. It reliably differentiates malignancy from challenging benign mimics, preventing misdiagnosis and guiding appropriate therapy. Clinicians should maintain a high suspicion for both occult malignancy and rare benign conditions in such stenotic lesions.
- Open Access
- 25 March 2025
- Published by MDPI AG in Preprints.org
Unexplained Urine Changes After EUS-HGS: A Rare Case Report
EUS-BD, including EUS-CDS and EUS-HGS, is an efficacious alternative to ERCP and its common complications are bile leak, infection, stent migration and bleeding. Here, we report an atypical case of a patient who developed dark green urine after receiving EUS-HGS, which we suspected to be caused by an abnormal biliary-vascular fistula. A 76-year-old woman diagnosed with pancreatic adenocarcinoma received EUS-HGS for relieving jaundice. The patient reported abdominal pain and chest tightness after the operation, with difficulty in urinating. X-ray suggested right-sided pleural effusion and dark green pleural effusion was drained out. However, the patient also developed dark green urine, which appeared everyday afternoon and disappeared automatically after intravenous treatment. The phenomenon was rare and interesting ,and also called for more alert on post-operative complication detection after EUS-BD operation.
- 25 March 2025
- Published by MDPI AG in Preprints.org
Open AccessUnexplained Urine Changes After EUS-HGS: A Rare Case Report
EUS-BD, including EUS-CDS and EUS-HGS, is an efficacious alternative to ERCP and its common complications are bile leak, infection, stent migration and bleeding. Here, we report an atypical case of a patient who developed dark green urine after receiving EUS-HGS, which we suspected to be caused by an abnormal biliary-vascular fistula. A 76-year-old woman diagnosed with pancreatic adenocarcinoma received EUS-HGS for relieving jaundice. The patient reported abdominal pain and chest tightness after the operation, with difficulty in urinating. X-ray suggested right-sided pleural effusion and dark green pleural effusion was drained out. However, the patient also developed dark green urine, which appeared everyday afternoon and disappeared automatically after intravenous treatment. The phenomenon was rare and interesting ,and also called for more alert on post-operative complication detection after EUS-BD operation.
- Open Access
- 1 January 2025
- Published by Wolters Kluwer Health in Endoscopic Ultrasound
- Vol. 14 (1) , 37-39
A rare complication of EUS-guided biliary drainage (with video)
- 1 January 2025
- Published by Wolters Kluwer Health in Endoscopic Ultrasound
- Vol. 14 (1) , 37-39
Open AccessA rare complication of EUS-guided biliary drainage (with video)
- Open Access
- 1 September 2024
- Published by Wolters Kluwer Health in Endoscopic Ultrasound
- Vol. 13 (5) , 293-299
The comparison of clinicopathological characteristics of two distinct manifestations of gastric signet ring cell carcinoma under EUS
Background and Objectives: There are two different endoscopic ultrasonographic manifestations of gastric signet ring cell carcinoma (GSRCC). No studies have been reported on the differences in the clinical profiles of patients based on EUS examination. We aim to study the variations in clinicopathological characteristics between two distinct endoscopic ultrasonographic manifestations of GSRCC. Methods: A total of 302 patients with GSRCC confirmed by pathological examination who underwent EUS were enrolled in the study. Based on the endoscopic ultrasonographic features, patients were categorized into two groups: type 1, where the entire layer structure disappeared, and type 2, where the layer structure was still present and appeared lymphomatoid. Clinicopathologic features were collected retrospectively and analyzed. Results: Compared with type 2 patients, type 1 patients tended to develop GSRCC at an older age (P = 0.033) and had higher serum levels of tumor markers and were more likely to experience anemia (P < 0.001) and weight loss (P < 0.001) during the disease progression. Significant increases in the tumor size (P < 0.001), thickness of the affected gastric wall (P < 0.001), and depth of tumor invasion (P < 0.001) were observed in type 1 patients. Furthermore, type 1 patients had higher prevalence of affected blood vessels (P < 0.001), nerves (P < 0.001), lymph nodes (P < 0.001), and peritoneal metastasis (P < 0.001). However, no difference was found in the duration of disease between the two groups, and all deficient mismatch repairs were observed in type 1 patients. Conclusions: The two distinct endoscopic ultrasonographic manifestations of GSRCC exhibited different clinicopathological characteristics, suggesting that they may represent different subtypes of the disease that require special attention in management strategies.
- 1 September 2024
- Published by Wolters Kluwer Health in Endoscopic Ultrasound
- Vol. 13 (5) , 293-299
Open AccessThe comparison of clinicopathological characteristics of two distinct manifestations of gastric signet ring cell carcinoma under EUS
Background and Objectives: There are two different endoscopic ultrasonographic manifestations of gastric signet ring cell carcinoma (GSRCC). No studies have been reported on the differences in the clinical profiles of patients based on EUS examination. We aim to study the variations in clinicopathological characteristics between two distinct endoscopic ultrasonographic manifestations of GSRCC. Methods: A total of 302 patients with GSRCC confirmed by pathological examination who underwent EUS were enrolled in the study. Based on the endoscopic ultrasonographic features, patients were categorized into two groups: type 1, where the entire layer structure disappeared, and type 2, where the layer structure was still present and appeared lymphomatoid. Clinicopathologic features were collected retrospectively and analyzed. Results: Compared with type 2 patients, type 1 patients tended to develop GSRCC at an older age (P = 0.033) and had higher serum levels of tumor markers and were more likely to experience anemia (P < 0.001) and weight loss (P < 0.001) during the disease progression. Significant increases in the tumor size (P < 0.001), thickness of the affected gastric wall (P < 0.001), and depth of tumor invasion (P < 0.001) were observed in type 1 patients. Furthermore, type 1 patients had higher prevalence of affected blood vessels (P < 0.001), nerves (P < 0.001), lymph nodes (P < 0.001), and peritoneal metastasis (P < 0.001). However, no difference was found in the duration of disease between the two groups, and all deficient mismatch repairs were observed in type 1 patients. Conclusions: The two distinct endoscopic ultrasonographic manifestations of GSRCC exhibited different clinicopathological characteristics, suggesting that they may represent different subtypes of the disease that require special attention in management strategies.
- 4 September 2015
- Published by Springer Nature in Digestive Diseases and Sciences
- Vol. 60 (12) , 3771-3781
Endoscopic Ultrasonography-Guided Biopsy for Differentiation of Benign and Malignant Pelvic Lesions: A Systematic Review and Meta-Analysis
Preoperative diagnosis of pelvic lesions remains challenging despite advances in imaging technologies. Endoscopic ultrasonography (EUS)-guided biopsy is an effective diagnostic modality for sampling the digestive tract and surrounding areas. However, a meta-analysis summarizing the diagnostic efficacy of EUS-guided biopsy for pelvic lesions has not been published. We aimed to evaluate the utility of EUS-guided biopsy in the diagnosis of pelvic lesions. Articles were identified via structured database search; only studies where pelvic lesions were confirmed by surgery or clinical follow-up were included. Data extracted were selected with strict criteria. A fixed-effects model was used to estimate the sensitivity, specificity, positive likelihood ratio (PLR), negative likelihood ratio (NLR), and diagnostic odds ratio (DOR). A summary receiver operating characteristic curve (SROC) was also constructed. Ten studies containing a total of 246 patients were included. The pooled sensitivity of EUS-guided biopsy for differential diagnosis of pelvic masses was 0.89 (95 % CI 0.83–0.94), and the specificity was 0.93 (95 % CI 0.86–0.97). The area under the SROC was 0.9631. The combined PLR, NLR, and DOR were 11.75 (95 % CI 5.90–23.43), 0.12 (95 % CI 0.07–0.20), and 100.06 (95 % CI 37.48–267.10) respectively. There is potential presence of publication bias in this meta-analysis. Our meta-analysis shows that EUS-guided biopsy is a powerful tool for differentiating pelvic masses with a high sensitivity and specificity. Furthermore, it is a safe procedure with low rate of complication, although more high-quality prospective studies are required to be done.
- 4 September 2015
- Published by Springer Nature in Digestive Diseases and Sciences
- Vol. 60 (12) , 3771-3781
Endoscopic Ultrasonography-Guided Biopsy for Differentiation of Benign and Malignant Pelvic Lesions: A Systematic Review and Meta-Analysis
Preoperative diagnosis of pelvic lesions remains challenging despite advances in imaging technologies. Endoscopic ultrasonography (EUS)-guided biopsy is an effective diagnostic modality for sampling the digestive tract and surrounding areas. However, a meta-analysis summarizing the diagnostic efficacy of EUS-guided biopsy for pelvic lesions has not been published. We aimed to evaluate the utility of EUS-guided biopsy in the diagnosis of pelvic lesions. Articles were identified via structured database search; only studies where pelvic lesions were confirmed by surgery or clinical follow-up were included. Data extracted were selected with strict criteria. A fixed-effects model was used to estimate the sensitivity, specificity, positive likelihood ratio (PLR), negative likelihood ratio (NLR), and diagnostic odds ratio (DOR). A summary receiver operating characteristic curve (SROC) was also constructed. Ten studies containing a total of 246 patients were included. The pooled sensitivity of EUS-guided biopsy for differential diagnosis of pelvic masses was 0.89 (95 % CI 0.83–0.94), and the specificity was 0.93 (95 % CI 0.86–0.97). The area under the SROC was 0.9631. The combined PLR, NLR, and DOR were 11.75 (95 % CI 5.90–23.43), 0.12 (95 % CI 0.07–0.20), and 100.06 (95 % CI 37.48–267.10) respectively. There is potential presence of publication bias in this meta-analysis. Our meta-analysis shows that EUS-guided biopsy is a powerful tool for differentiating pelvic masses with a high sensitivity and specificity. Furthermore, it is a safe procedure with low rate of complication, although more high-quality prospective studies are required to be done.
- Open Access
- 26 September 2014
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 9 (9) , e108014
Induction of M2 Polarization in Primary Culture Liver Macrophages from Rats with Acute Pancreatitis
Systemic inflammatory response syndrome (SIRS), a major process of severe acute pancreatitis (SAP), usually occurs after various activated proinflammatory cytokines, which are produced by macrophages such as liver macrophages. Macrophages can secrete not only proinflammatory mediators but also inhibitory inflammatory cytokines such as IL-10, leading to two different functional states defined as “polarization”. The main purpose of this study was to demonstrate the polarization of liver macrophages during severe acute pancreatitis and to explore whether the polarization of these activated Liver macrophages could be reversed in vitro. Liver macrophages were isolated from rats with acute pancreatitis. These primary culture macrophages were treated with IL-4 or regulatory T cells in vitro to reverse their polarization and was evaluated by measuring M1/M2 marker expression using real time PCR and immunofluorescence staining. Acute pancreatitis was induced successfully by intra-pancreatic ductal injection of 5% sodium taurocholate. The liver macrophages demonstrated M1 polarization from 4 h to 16 h after the onset of acute pancreatitis. However, after IL-4 or Treg treatment, the polarization of the liver macrophages was reversed as indicated by increased expression of M2 markers and reduced expression of M1 markers. Furthermore, the effect of Treg on modulating macrophage polarization was slightly better than that of IL-4 in vitro. Liver macrophages, a pivotal cell type in the pathogenesis of SAP, become M1 polarized during pancreatic inflammation. Treatment of these cells with IL-4 and Treg can reverse this activation in vitro. This method of altering macrophage polarization could be a prospective therapy for SAP.
- 26 September 2014
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 9 (9) , e108014
Open AccessInduction of M2 Polarization in Primary Culture Liver Macrophages from Rats with Acute Pancreatitis
Systemic inflammatory response syndrome (SIRS), a major process of severe acute pancreatitis (SAP), usually occurs after various activated proinflammatory cytokines, which are produced by macrophages such as liver macrophages. Macrophages can secrete not only proinflammatory mediators but also inhibitory inflammatory cytokines such as IL-10, leading to two different functional states defined as “polarization”. The main purpose of this study was to demonstrate the polarization of liver macrophages during severe acute pancreatitis and to explore whether the polarization of these activated Liver macrophages could be reversed in vitro. Liver macrophages were isolated from rats with acute pancreatitis. These primary culture macrophages were treated with IL-4 or regulatory T cells in vitro to reverse their polarization and was evaluated by measuring M1/M2 marker expression using real time PCR and immunofluorescence staining. Acute pancreatitis was induced successfully by intra-pancreatic ductal injection of 5% sodium taurocholate. The liver macrophages demonstrated M1 polarization from 4 h to 16 h after the onset of acute pancreatitis. However, after IL-4 or Treg treatment, the polarization of the liver macrophages was reversed as indicated by increased expression of M2 markers and reduced expression of M1 markers. Furthermore, the effect of Treg on modulating macrophage polarization was slightly better than that of IL-4 in vitro. Liver macrophages, a pivotal cell type in the pathogenesis of SAP, become M1 polarized during pancreatic inflammation. Treatment of these cells with IL-4 and Treg can reverse this activation in vitro. This method of altering macrophage polarization could be a prospective therapy for SAP.
- 21 April 2014
- Published by Higher Education Press in Frontiers of Optoelectronics
- Vol. 8 (2) , 141-151
Two-photon microscopy in pre-clinical and clinical cancer research
The applications of two-photon microscopy (TPM) on pre-clinical and clinical study of human cancer and diseases are reviewed in this paper. First, the principle of two-photon excitation (TPE) is introduced. The resulting advantages of TPM for imaging studies of animal models and human samples are then elaborated. Subsequently, the applications of TPM on various aspects of tumor studies, including tumor angiogenesis, invasion and metastasis, tumor microenvironment and metabolism are introduced. Furthermore, studies of TPM on clinical human skin biopsy and the development of two-photon microendoscopy are reviewed. Finally, potential future directions are discussed.
- 21 April 2014
- Published by Higher Education Press in Frontiers of Optoelectronics
- Vol. 8 (2) , 141-151
Two-photon microscopy in pre-clinical and clinical cancer research
The applications of two-photon microscopy (TPM) on pre-clinical and clinical study of human cancer and diseases are reviewed in this paper. First, the principle of two-photon excitation (TPE) is introduced. The resulting advantages of TPM for imaging studies of animal models and human samples are then elaborated. Subsequently, the applications of TPM on various aspects of tumor studies, including tumor angiogenesis, invasion and metastasis, tumor microenvironment and metabolism are introduced. Furthermore, studies of TPM on clinical human skin biopsy and the development of two-photon microendoscopy are reviewed. Finally, potential future directions are discussed.
- 20 October 2013
- Published by Springer Nature in Current Medical Science
- Vol. 33 (5) , 661-665
Impact of probiotics on toll-like receptor 4 expression in an experimental model of ulcerative colitis
Toll-like receptors (TLRs) are key components of the innate immune system which trigger antimicrobial host defense responses. This study aimed to investigate the impact of probiotics (Lactobacillus, Bifiidobacterium) on the expression of TLR4 and tumor necrosis factor-alpha (TNF-α) in the colon mucosa of rat experimental ulcerative colitis model induced by trinitrobenzene sulfonic acid (TNBS)/ethanol and immune complexes. The gross and histological changes of the colonic mucosa were observed and assessed by the means-standard deviation and independent samples t-test. The protein expression levels of TLR4 and TNF-α were detected by using immunohistochemistry and Western blotting, respectively. It was revealed that there was visible infiltration of inflammatory cells, formation of crypt abscess, and the reduction of goblet cells in the colon tissue of experimental models. As compared with the control group, the levels of TLR4 and TNF-α protein were significantly increased in the model group (P0.05), whereas significant reductions were shown in rats which were treated with probiotics for four weeks as compared with the model group (P<0.01). There was no significant difference between two probiotics-treated groups. Our results implied that probiotics were likely to play a key role in protecting ulcerative colitis by reducing the inflammatory factor TNF-α expression through inhibiting the TLR4 expression in the colon tissue of experimental models.
- 20 October 2013
- Published by Springer Nature in Current Medical Science
- Vol. 33 (5) , 661-665
Impact of probiotics on toll-like receptor 4 expression in an experimental model of ulcerative colitis
Toll-like receptors (TLRs) are key components of the innate immune system which trigger antimicrobial host defense responses. This study aimed to investigate the impact of probiotics (Lactobacillus, Bifiidobacterium) on the expression of TLR4 and tumor necrosis factor-alpha (TNF-α) in the colon mucosa of rat experimental ulcerative colitis model induced by trinitrobenzene sulfonic acid (TNBS)/ethanol and immune complexes. The gross and histological changes of the colonic mucosa were observed and assessed by the means-standard deviation and independent samples t-test. The protein expression levels of TLR4 and TNF-α were detected by using immunohistochemistry and Western blotting, respectively. It was revealed that there was visible infiltration of inflammatory cells, formation of crypt abscess, and the reduction of goblet cells in the colon tissue of experimental models. As compared with the control group, the levels of TLR4 and TNF-α protein were significantly increased in the model group (P0.05), whereas significant reductions were shown in rats which were treated with probiotics for four weeks as compared with the model group (P<0.01). There was no significant difference between two probiotics-treated groups. Our results implied that probiotics were likely to play a key role in protecting ulcerative colitis by reducing the inflammatory factor TNF-α expression through inhibiting the TLR4 expression in the colon tissue of experimental models.